In 2023, Anthony P. Bihl III earned $584.36K in total compensation at Bioventus, including $559.65K salary and $74.00 bonus. Most recently acquired 800,000 shares in Sep 2024. Currently holds stock worth $1.17M. 2+ years at the helm of Bioventus.
Compensation History
Annual executive compensation data for Anthony P. Bihl III, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$584.36K
Salary
$559.65K
Bonus
$74.00
Other
$24.64K
Salary
$559.65KBoard Justification
The compensation philosophy aligns with company performance, peer benchmarking, and retention strategies, focusing on performance-based incentives.
Bonus
$74.00Board Justification
The bonus for 2023 was based on performance metrics and was paid in cash as he was no longer an employee at the time of grant.
Other Compensation
$24.64KBoard Justification
Other compensation includes matching 401(k) contributions and life insurance premiums paid by the company.
Restricted Stock
Board Justification
No stock awards vested in 2023 as Mr. Bihl's stock options and RSUs were accelerated and vested on January 9, 2024, after his termination.
Performance Metrics
The performance metrics for the bonus included Global Revenue, Adjusted Global EBITDA, and Quality.
Anthony P. Bihl III
CEO of Bioventus
Education
Bachelor of Science in Business Administration from Pennsylvania State University
Field of Expertise
Business & Management
Sector of Economy
Healthcare
CEO of Bioventus for
2 years 8 months (Apr 2023 - Present)
Previous Experience
CEO of Diagnostics Division of Siemens Medical Solutions
Other Bioventus CEOs
Holdings
Track Anthony P. Bihl III's stock holdings and portfolio value over time.
Insider Trading
Anthony P. Bihl III's recent stock transactions, purchases, and sales filed with the SEC.
$165.08K
BVS at $4.14/share
Aug 18, 2023
Purchase
$290.99K
BVS at $2.33/share
May 23, 2023
Purchase
Rivals
Compare Anthony P. Bihl III with competitor CEOs and industry peers.